Decible reports an international sales increase, largely thanks to AgMedica Bioscience. Discover more about their Q1 2025 results.

Decibel Cannabis Company Inc. (TSXV:DB) (OTCQB:DBCCF) hat den zweiten und letzten Abschluss seiner zuvor angekündigten unverbindlichen privaten Platzierung seiner Stammaktien zu einem Preis von 0,06 USD pro Stammaktie

Haywood Capital Markets analyst Neal Gilmer maintained his “Purchase” ranking and $0.25 goal worth on Decibel Hashish Haywood Capital Markets analyst Neal Gilmer maintained his “Purchase” ranking and $0.25 goal worth on Decibel Hashish Firm (Decibel Hashish Firm Inventory Quote, Chart, Information, Analysts, Financials TSXV:DB) in an Aug. 21 report, after the corporate posted stronger-than-expected second-quarter outcomes pushed by worldwide gross sales and its AgMedica acquisition. “Decibel reported very robust Q2/25 monetary outcomes representing important progress over final yr, partially as a result of AgMedica acquisition,” Gilmer stated. “Strong margins and value containment additionally produced EBITDA above our forecast.” …

Haywood Capital Markets analyst Neal Gilmer maintained his “Buy” rating and $0.25 target price on Decibel Cannabis Haywood Capital Markets analyst Neal Gilmer maintained his “Buy” rating and $0.25 target price on Decibel Cannabis Company (Decibel Cannabis Company Stock Quote, Chart, News, Analysts, Financials TSXV:DB) in an Aug. 21 report, after the company posted stronger-than-expected second-quarter results driven by international sales and its AgMedica acquisition.

Haywood Capital Markets analyst Neal Gilmer maintained his “Buy” rating and $0.25 target price on Decibel Cannabis Haywood Capital Markets analyst Neal Gilmer maintained his “Buy” rating and $0.25 target price on Decibel Cannabis Company (Decibel Cannabis Company Stock Quote, Chart, News, Analysts, Financials TSXV:DB) in an Aug. 21 report, after the company posted stronger-than-expected second-quarter results driven by international sales and its AgMedica acquisition.

Haywood Capital Markets analyst Neal Gilmer maintained his “Purchase” ranking and $0.25 goal worth on Decibel Hashish Haywood Capital Markets analyst Neal Gilmer maintained his “Purchase” ranking and $0.25 goal worth on Decibel Hashish Firm (Decibel Hashish Firm Inventory Quote, Chart, Information, Analysts, Financials TSXV:DB) in an Aug. 21 report, after the corporate posted stronger-than-expected second-quarter outcomes pushed by worldwide gross sales and its AgMedica acquisition. “Decibel reported very robust Q2/25 monetary outcomes representing important progress over final yr, partially as a result of AgMedica acquisition,” Gilmer stated. “Strong margins and value containment additionally produced EBITDA above our forecast.” …

Decibel Cannabis Company Inc. reported $44.4 million in gross revenue for the three months ending June 30, 2025, net revenue of $29.8 million and net income of $1.6 million.

Decibel Cannabis Company showcases a remarkable 22% revenue growth in 2025 and shares a promising outlook for 2026 amid strategic expansions.

Decibel Cannabis Company has announced impressive financial results for the third quarter of 2025, showcasing significant revenue growth and international expansion.

Decibel Cannabis Company highlights significant revenue and profitability growth for the second quarter of 2025, driven by international sales.

Decibel Cannabis Company shares its unaudited financial results for Q1 2025, showcasing revenue growth, cost management, and plans for future expansion.

Decibel Cannabis Company Inc. shares strong year-end financial outcomes for 2024 and outlines ambitious growth plans for 2025, focusing on profitability and international expansion.